Press Releases

PANTHERx® Rare Selected by Soleno Therapeutics for the Distribution of VYKAT™ XR

PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Soleno Therapeutics as the specialty pharmacy for the distribution of VYKAT™ XR (diazoxide...
Read More

PANTHERx® Rare Selected by Upsher-Smith Laboratories, LLC as Specialty Pharmacy for VIGAFYDE™ (vigabatrin) Oral Solution

PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Upsher-Smith for the distribution of VIGAFYDE™ (vigabatrin), a ready-to-use, concentrated...
Read More

PANTHERx® Rare Named to USA Today’s List of Top Workplaces for 2025

PITTSBURGH – PANTHERx® Rare, one of the nation’s largest and fastest growing rare disease specialty pharmacies, announced today that it has been recognized as one of the Top Places to Work by USA Today. This prestigious recognition highlights...
Read More

PANTHERx® Rare Selected by Ionis as Specialty Pharmacy for TRYNGOLZA™ (olezarsen)

PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Ionis Pharmaceuticals, Inc. for the distribution of TRYNGOLZA™ (olezarsen), the first...
Read More

Neurocrine Biosciences, Inc. Selects PANTHERx® Rare Specialty Pharmacy for Distribution of Crenessity™ (crinecerfont)

PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Neurocrine Biosciences, Inc. for the distribution of CRENESSITY™ (crinecerfont), an...
Read More

Ascendis Pharma Selects PANTHERx® Rare for the Distribution of YORVIPATH® (palopegteriparatide)

PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it is partnering with Ascendis Pharma for the distribution of YORVIPATH®, a FDA approved parathyroid hormone...
Read More
1 2 3 4 11